Pathogen-Targeted Clinical Development to Address Unmet Medical Need: Design, Safety, and Efficacy of the ATTACK Trial

There is a crucial need for novel antibiotics to stem the tide of antimicrobial resistance, particularly against difficult to treat gram-negative pathogens like Acinetobacter baumannii-calcoaceticus complex (ABC). An innovative approach to addressing antimicrobial resistance may be pathogen-targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Watkins, Richard R, Du, Bin, Isaacs, Robin, Altarac, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
SUL-DUR Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150271/
https://www.ncbi.nlm.nih.gov/pubmed/37125468
http://dx.doi.org/10.1093/cid/ciad097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150271/
https://www.ncbi.nlm.nih.gov/pubmed/37125468
http://dx.doi.org/10.1093/cid/ciad097

Ejemplares similares